摘要
医学伦理是涉及生物学、医学、环境学、教育、科学研究、经济学、人类学等众多学科的一项伦理研究。医学期刊对刊发的学术论文负有伦理审查的责任,2023年2月,国家卫生健康委、教育部、科技部、国家中医药局四部门颁布新版《涉及人的生命科学和医学研究伦理审查办法》,其中第二十九条明确规定,学术期刊在刊发涉及人的生命科学和医学研究成果时,应当确认该研究经过伦理审查委员会的批准,研究者应当提供相关证明。本“共识”广泛征求了医学院校、临床研究、药物研究的专家意见,旨在讨论医学伦理的发展及国家相关法律法规,对医学伦理审查具有重要的指导意义,并确认了医学期刊对刊发学术论文负有伦理审查的责任。
Medical ethics is recognized as one ethical research involvingmulti-disciplines such as biology,medicine,environmental science,education,scientific research,economics,and anthropology,etc.Medical journals have the responsibility for ethical review of academic papers.In February 2023,the National Health Commission,the Ministry of Education,the Ministry of Science and Technology,and the State Administration of Traditional Chinese Medicine issued a new version of the“Ethical Review Measures for Life Sciences and Medical Research Involving Human Beings”.Article 29 clearly stipulates that when academic journals publish research result related to human life science and medical research,they should confirm that the research has been approved by the ethics review committee,and researchers should provide relevant proof.This“consensus”has extensively solicited expert opinions from medical schools,clinical research,and drug research,aimingto discuss the development of medical ethics and relevant national laws and regulations,the important guiding significance of medical ethics review,and confirm that medical journals have the responsibility of ethical review for publishing academic papers.
作者
《中国骨质疏松杂志》医学论文伦理审查专家共识编写组
张萌萌
Expert Consensus Writing Group for Ethical Review of Medical Papers in the Chinese Journal of Osteoporosis;ZHANG Mengmeng(Chinese Journal of Osteoporosis,Beijing 100102,China;不详)
出处
《中国骨质疏松杂志》
北大核心
2025年第2期308-312,共5页
Chinese Journal of Osteoporosis
关键词
医学伦理
伦理原则
伦理审查
知情同意
medical ethics
ethical principles
ethical review
informed consent
